Response by Cohen et al to Letter Regarding Article, 'Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19'

首页> 外文期刊>Circulation research: a journal of the American Heart Association >Response by Cohen et al to Letter Regarding Article, 'Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19'

【24h】

Response by Cohen et al to Letter Regarding Article, 'Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19'

机译：Cohen等人对文章的回应，“血管紧张素转化酶抑制剂和血管紧张素II受体阻滞剂具有死亡率与Covid-19的高血压患者死亡率的关键词，血管紧张素II受体阻滞剂的关联患者

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Circulation research: a journal of the American Heart Association》 |2020年第12期|共2页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Response by Cohen et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19" [J] . Circulation research: a journal of the American Heart Association . 2020,第12期

机译：Cohen等人对文章的回应，“血管紧张素转化酶抑制剂和血管紧张素II受体阻滞剂具有死亡率与Covid-19的高血压患者死亡率的关键词，血管紧张素II受体阻滞剂的关联患者
2. Response by Zhang et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19" [J] . Circulation research: a journal of the American Heart Association . 2020,第12期

机译：张等人对文章的回应，“住院生使用血管紧张素转化酶抑制剂和血管紧张素II受体阻滞剂的关键词，患有Covid-19的高血压患者的死亡率阻滞剂患者死亡率”
3. Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19 [J] . Circulation research: a journal of the American Heart Association . 2020,第12期

机译：住院使用血管紧张素转化酶抑制剂和血管紧张素II受体阻滞剂在Covid-19住院治疗高血压患者中死亡率的血管紧张素II受体阻滞剂
4. The Prevalence of Potential Clinically Significant Drug Interactions with Angiotensin-Converting Enzyme Inhibitors in Slovenia [C] . Marjetka P., Brane L, Polonca F. European Congress of Pharmacology . 2012

机译：斯洛文尼亚血管紧张素转化酶抑制剂潜在临床显着的药物相互作用的患病率
5. Comparison of monotherapy with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in improving health outcomes among veteran patients with type 2 diabetes. [D] . Campbell, Heather M. 2011

机译：与血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂单一疗法改善2型糖尿病退伍军人患者健康结局的比较。
6. Response by Cohen et al to Letter Regarding Article Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19 [O] . Jordana B. Cohen, Thomas C. Hanff, Andrew M. South, -1

机译：Cohen等人对信函的答复：住院使用COVID-19的高血压患者中死亡率与血管紧张素转换酶抑制剂和血管紧张素II受体阻滞剂的住院使用的关联
7. Correction to: Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19 [O] . 2020

机译：矫正：住院生使用血管紧张素转化酶抑制剂和血管紧张素II受体阻滞剂，高血压患者与Covid-19住院的患者死亡率

Response by Cohen et al to Letter Regarding Article, 'Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19'

著录项

相似文献

相关主题

期刊订阅